0001209191-20-012197.txt : 20200224 0001209191-20-012197.hdr.sgml : 20200224 20200224183833 ACCESSION NUMBER: 0001209191-20-012197 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200224 FILED AS OF DATE: 20200224 DATE AS OF CHANGE: 20200224 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gulfo Adele M. CENTRAL INDEX KEY: 0001647102 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37929 FILM NUMBER: 20646390 MAIL ADDRESS: STREET 1: ONE NEENAH CENTER, 4TH FLOOR STREET 2: P.O. BOX 669 CITY: NEENAH STATE: WI ZIP: 54957 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Myovant Sciences Ltd. CENTRAL INDEX KEY: 0001679082 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: CA FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: SUITE 1, 3RD FLOOR STREET 2: 11-12 ST. JAMES SQUARE CITY: LONDON STATE: X0 ZIP: SW1Y 4LB BUSINESS PHONE: 44(0)207 400 3347 MAIL ADDRESS: STREET 1: SUITE 1, 3RD FLOOR STREET 2: 11-12 ST. JAMES SQUARE CITY: LONDON STATE: X0 ZIP: SW1Y 4LB 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-02-24 0 0001679082 Myovant Sciences Ltd. MYOV 0001647102 Gulfo Adele M. C/O MYOVANT SCIENCES INC. 2000 SIERRA POINT PARKWAY, 9TH FLOOR BRISBANE CA 94005 1 0 0 0 Stock Option (Right to Buy) 11.17 2020-02-24 4 A 0 45000 0.00 A 2030-02-23 Common Stock 45000 45000 D 1/3rd of the shares underlying the option vest and become exercisable on February 24, 2021, with the balance of the shares vesting in eight equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer through the vesting date. /s/ Matthew Lang, Attorney-in-fact 2020-02-24